Open Access Open Access  Restricted Access Subscription Access

Oral Leukoplakia


Affiliations
1 Department of Oral Surgery, Medical University Plovdiv, Bulgaria
 

Oral leukoplakia is defined as a predominantly white lesion of the oral mucosa that cannot be characterized as any other definable lesion; however, the lesion must be confirmed histopathologically by biopsy in order to discuss malignant transformation of oral leukoplakia. Malignant transformation rates of oral leukoplakia range from 0.13 to 17.5%, while the rates of five-year cumulative malignant transformation range from 1.2 to 14.5%. In this review were described some datas about the frequency, etiology and pathogenesis of oral leukoplakia. Clinical symptoms and treatment methods were described. The basic information sources were up to date articles. The author's results were retrospectively analysed.

Keywords

Dysplasia, Oral Leukoplakia, Treatment.
User
Notifications
Font Size


  • Аmagasa T, Yamashiro M, Ishikawa H. Oral Leukoplakia related to Malignant Transformation. Oral Science International 2006;3(2):45-55.
  • Sdubba JJ. Oral Leukoplakia Critical Reviews in Oral Biology & Medicine 1995;6(2):147-60.
  • Liu W. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer 2010;10:685.
  • Lin L, Wang J, Liu D, Liu S, Xu H, Ji N, et al. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma. Scientific Reports 2016;6:26757.
  • Uma Maheswari TN. Treatment of oral leukoplakia with antioxidants – a systematic review. Int J Pharm Bio Sci 2013;4(4):33–41.
  • Singh M, Krishanappa R, Bagewadi A, Keluskar V. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncology 2004;40(6):591–6.
  • Selvam NP, Sadaksharam J, Singaravelu G, Ramu R. Treatment of oral leukoplakia with photodynamic therapy: A pilot study. J Can Res Ther 2015;11(2):464-7.
  • Cheng SJ, Chen HM, Chiang CP. Cryogun cryotherapy is the first-line treatment of choice for oral leukoplakia. Journal of Dental Sciences 2015;10(2):223-4.
  • Pathak H, Mohanty S, Urs AB, Dabas J. Treatment of Oral Mucosal Lesions by Scalpel Excision and Platelet-Rich Fibrin Membrane Grafting: A Review of 26 Sites. Journal of Oral and Maxillofacial Surgery 2015;73(9):1865-74.
  • Praveen KNS, Veeraraghavan G, Reddy RS, Kotha P, Koneru J, Yelisetty K. Management of Oral Leukoplakia Using Diode Laser: A Pilot Study. British Journal of Medicine & Medical Research 2015;10(7):1-6.
  • Chiniforush N, Kamali A, Shahabi S, Bassir SH. Leukoplakia Removal by Carbon Dioxide Laser (CO2) Laser. J Lasers Med Sci 2012;3(1):33-5.
  • Vivek V, Jayasree RS, Balan A, Sreelatha KT, Gupta AK. Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery. Lasers in Medical Science 2008;23:375.

Abstract Views: 215

PDF Views: 124




  • Oral Leukoplakia

Abstract Views: 215  |  PDF Views: 124

Authors

Tsvetan Borisov Tsvetanov
Department of Oral Surgery, Medical University Plovdiv, Bulgaria

Abstract


Oral leukoplakia is defined as a predominantly white lesion of the oral mucosa that cannot be characterized as any other definable lesion; however, the lesion must be confirmed histopathologically by biopsy in order to discuss malignant transformation of oral leukoplakia. Malignant transformation rates of oral leukoplakia range from 0.13 to 17.5%, while the rates of five-year cumulative malignant transformation range from 1.2 to 14.5%. In this review were described some datas about the frequency, etiology and pathogenesis of oral leukoplakia. Clinical symptoms and treatment methods were described. The basic information sources were up to date articles. The author's results were retrospectively analysed.

Keywords


Dysplasia, Oral Leukoplakia, Treatment.

References





DOI: https://doi.org/10.18311/ijmds%2F2017%2F125573